Femasys Inc. Research and Development Expense
Femasys Inc. (FEMY) reported Research and Development Expense of $1.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Femasys Inc. research and development expense for the quarter ending 2026-06-30 was $1.95M, a 37.64% increase year-over-year.
- Femasys Inc. research and development expense for the quarter ending 2026-03-31 was $1.31M, a 55.89% decline year-over-year.
- Femasys Inc. research and development expense for the quarter ending 2025-12-31 was $1.81M, a 16.33% decline year-over-year.
- Femasys Inc. research and development expense for the quarter ending 2025-09-30 was $1.38M, a 40.00% decline year-over-year.
- Femasys Inc. research and development expense for fiscal 2025 was $7.58M, a 7.78% decline from fiscal 2024.
- Femasys Inc. research and development expense for fiscal 2024 was $8.22M, a 13.98% increase from fiscal 2023.
- Femasys Inc. research and development expense for fiscal 2023 was $7.21M, a 23.99% increase from fiscal 2022.
- Femasys Inc. research and development expense for fiscal 2022 was $5.81M, a 42.34% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.95M 10-Q · filed 2026-08-14 | $3.26M 10-Q · filed 2026-08-14 | $5.07M derived: sum of 3 quarters · filed 2026-08-14 | $6.45M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-08 | $3.12M derived: sum of 2 quarters · filed 2026-05-08 | $4.50M derived: sum of 3 quarters · filed 2026-05-08 | $5.92M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.19M derived: sum of 2 quarters · filed 2026-03-31 | $4.61M derived: sum of 3 quarters · filed 2026-08-14 | $7.58M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.38M 10-Q · filed 2025-11-14 | $2.80M derived: sum of 2 quarters · filed 2026-08-14 | $5.76M 10-Q · filed 2025-11-14 | $7.93M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.41M 10-Q · filed 2026-08-14 | $4.38M 10-Q · filed 2026-08-14 | $6.55M derived: sum of 3 quarters · filed 2026-08-14 | $8.85M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.97M 10-Q · filed 2026-05-08 | $5.14M derived: sum of 2 quarters · filed 2026-05-08 | $7.44M derived: sum of 3 quarters · filed 2026-05-08 | $9.41M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.47M derived: sum of 2 quarters · filed 2026-03-31 | $6.45M derived: sum of 3 quarters · filed 2026-03-31 | $8.22M 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.30M 10-Q · filed 2025-11-14 | $4.28M derived: sum of 2 quarters · filed 2025-11-14 | $6.05M 10-Q · filed 2025-11-14 | $8.12M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.98M 10-Q · filed 2025-08-08 | $3.75M 10-Q · filed 2025-08-08 | $5.82M derived: sum of 3 quarters · filed 2025-08-08 | $7.89M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.77M 10-Q · filed 2025-05-08 | $3.84M derived: sum of 2 quarters · filed 2025-05-08 | $5.91M derived: sum of 3 quarters · filed 2025-05-08 | $7.44M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.14M derived: sum of 2 quarters · filed 2025-03-27 | $5.67M derived: sum of 3 quarters · filed 2025-03-27 | $7.21M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.07M 10-Q · filed 2024-11-12 | $3.60M derived: sum of 2 quarters · filed 2024-11-12 | $5.14M 10-Q · filed 2024-11-12 | $6.41M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.53M 10-Q · filed 2024-08-08 | $3.06M 10-Q · filed 2024-08-08 | $4.34M derived: sum of 3 quarters · filed 2024-08-08 | $5.98M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.54M 10-Q · filed 2024-05-09 | $2.81M derived: sum of 2 quarters · filed 2024-05-09 | $4.46M derived: sum of 3 quarters · filed 2024-05-09 | $5.93M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.92M derived: sum of 2 quarters · filed 2024-03-28 | $4.39M derived: sum of 3 quarters · filed 2024-03-28 | $5.81M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.65M 10-Q · filed 2023-11-14 | $3.12M derived: sum of 2 quarters · filed 2023-11-14 | $4.54M 10-Q · filed 2023-11-14 | $5.60M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.47M 10-Q · filed 2023-08-10 | $2.89M 10-Q · filed 2023-08-10 | $3.95M derived: sum of 3 quarters · filed 2023-08-10 | $5.09M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.42M 10-Q · filed 2023-05-11 | $2.47M derived: sum of 2 quarters · filed 2023-07-24 | $3.62M derived: sum of 3 quarters · filed 2023-07-24 | $4.51M derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | $1.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $2.19M derived: sum of 2 quarters · filed 2023-07-24 | $3.09M derived: sum of 3 quarters · filed 2023-07-24 | $4.08M 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $1.14M 10-Q · filed 2022-11-10 | $2.04M derived: sum of 2 quarters · filed 2022-11-10 | $3.03M 10-Q · filed 2022-11-10 | $3.93M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $894.87K 10-Q · filed 2022-08-10 | $1.89M 10-Q · filed 2022-08-10 | $2.79M derived: sum of 3 quarters · filed 2022-08-10 | $3.78M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $995.02K 10-Q · filed 2022-05-11 | $1.89M derived: sum of 2 quarters · filed 2022-05-11 | $2.89M derived: sum of 3 quarters · filed 2022-05-11 | $3.77M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $895.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.89M derived: sum of 2 quarters · filed 2022-03-24 | $2.78M derived: sum of 3 quarters · filed 2022-03-24 | $4.13M 10-K · filed 2022-03-24 |
| 2020-09-30 | $995.62K 10-Q · filed 2021-11-12 | $1.88M derived: sum of 2 quarters · filed 2021-11-12 | $3.24M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $888.70K 10-Q · filed 2021-08-11 | $2.24M 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |